The head of drugmaker Eli Lilly, which sells the popular weight ... right mechanism” to bolster U.S. drug manufacturing, Lilly Chief Executive David Ricks said on a conference call with analysts ...

President Trump signed an executive ... results, Eli Lilly's stock movement remained flat over the last month, aligning with broader market trends, which also showed little change.

U.S. President Donald Trump's executive order on drug pricing threatens Roche's planned $50 billion investment in the United ...

USPS said its controllable loss was $848 million, up from $317 million in the same quarter last year as mail volume continues ...

Indianapolis: Eli Lilly and Company has announced executive leadership transitions affecting its ... Ricks, Lilly's chair and CEO. "With these changes, we will create the additional focus we need to ...

Lilly announced several changes to its executive leadership team. 1 These changes are mostly related to the company’s ...

American Medical Association named John J. Whyte, MD, MPH as its next CEO and EVP, effective July 1. Centivo hired Sarah ...

A consultancy’s new ranking of drug company R&D shows Eli Lilly has risen to the top of the drug development heap, while ...

Now, this won't come as too much of a surprise to Eli Lilly and its peers. A few weeks ago, the company's CEO, David Ricks, ...

Despite these headline-grabbing results, Eli Lilly's stock movement remained flat over the last month, aligning with broader market trends, which also showed little change. The company's ...